T. Rowe Price Emerging Markets Stock (PRMSX)
Nasdaq • Currently up 0.40 (+0.71%) in today's trading session
1 member of Congress has disclosed 3 trades in T. Rowe Price Emerging Markets Stock (PRMSX) via STOCK Act filings. The most recent disclosure was a sale by Nathaniel Moran on 25 September 2023. Aggregate disclosed activity totals roughly $73K in sales (midpoint estimates from bracketed disclosure amounts).
T. Rowe Price Emerging Markets Stock is currently trading at $56.85, positioned at 86% of its 52-week range ($39.15 – $59.70).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
T. Rowe Price Emerging Markets Stock Price History and Technical Analysis
Congressional Trading Activity for PRMSX
| No data | |||||||
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about PRMSX
- Which members of Congress have traded PRMSX?
- 1 member of Congress has disclosed 3 trade in T. Rowe Price Emerging Markets Stock (PRMSX) under the STOCK Act: Nathaniel Moran.
- When was PRMSX most recently disclosed by Congress?
- The most recent PRMSX disclosure was a sale by Nathaniel Moran on 25 September 2023.
- What is the total disclosed congressional trading volume for PRMSX?
- Members of Congress have disclosed approximately $73K in PRMSX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in PRMSX?
- This PRMSX page updates as soon as new STOCK Act disclosures are filed for T. Rowe Price Emerging Markets Stock. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track PRMSX in Congress
See when politicians buy or sell this stock